Acetyl aspartyl ferritin

乙酰基天门冬氨酰铁蛋白

Report date: 2023/12/26 13:20:01

Base Information

Drug NameAcetyl aspartyl ferritin
Drug Alias NameN/A
ClassificationBiologics > Protein drugs
Mechanisms of ActionIron Supplements
TargetsNot applicable
Therapy Area/IndicationsAnemia, Iron-Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAesculapius Farmaceutici Srl
China Registration ClassN/A

Develop Information

Active CompaniesMitim SrlAesculapius Farmaceutici SrlGuangdong Liwei Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAnemia, Iron-Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A